96 related articles for article (PubMed ID: 8174475)
1. [Studies on immunohistochemical localization and immunotargeting of monoclonal antibody against human hepatocellular carcinoma].
Ji YY
Zhonghua Zhong Liu Za Zhi; 1993 Sep; 15(5):335-8. PubMed ID: 8174475
[TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical localization of ganglioside components in hepatocellular carcinoma and liver cirrhosis using monoclonal antibody.
Tanno M; Yamada H; Kyomasu Y; Inaniwa Y; Hano H; Myoga A
Lab Invest; 1993 Apr; 68(4):456-64. PubMed ID: 7683070
[TBL] [Abstract][Full Text] [Related]
3. [Immunohistochemical study of hepatitis C virus core antigen and HBxAg in liver cirrhosis and hepatocellular carcinoma tissues].
Wang C; Wang W; Lu H
Zhonghua Zhong Liu Za Zhi; 1997 Mar; 19(2):85-8. PubMed ID: 10743066
[TBL] [Abstract][Full Text] [Related]
4. Radioimmunodetection and autoradiographic localization of monoclonal antibody against human hepatocellular carcinoma in xenografts.
Ji YY; Liu YF; Chen ZN
Cancer; 1992 Apr; 69(8):2055-9. PubMed ID: 1311979
[TBL] [Abstract][Full Text] [Related]
5. [Expression of NET-1 gene and protein in hepatocellular carcinoma and related tissues].
Chen L; Shen AG; Wang GL; Lu P; Li XY
Ai Zheng; 2006 Mar; 25(3):320-5. PubMed ID: 16536986
[TBL] [Abstract][Full Text] [Related]
6. A humanized monoclonal antibody constructed from intronless expression vectors targets human hepatocellular carcinoma cells.
Chan KT; Cheng SC; Xie H; Xie Y
Biochem Biophys Res Commun; 2001 Jun; 284(1):157-67. PubMed ID: 11374885
[TBL] [Abstract][Full Text] [Related]
7. [Selective deposition of agrin in the microvasculature of hepatocellular carcinoma: aspects in pathogenesis and differential diagnosis].
Tátrai P
Magy Onkol; 2008 Dec; 52(4):379-83. PubMed ID: 19068466
[TBL] [Abstract][Full Text] [Related]
8. Utilization of antihepatocyte clone OCH1E5 (Hep Par 1) in histological evaluation of liver tumors.
Amarapurkar AD; Rege JD; Joshi AS; Vaiphei K; Amarapurkar DN
Indian J Pathol Microbiol; 2006 Jul; 49(3):341-4. PubMed ID: 17001880
[TBL] [Abstract][Full Text] [Related]
9. Identification of c-Yes expression in the nuclei of hepatocellular carcinoma cells: involvement in the early stages of hepatocarcinogenesis.
Nonomura T; Masaki T; Morishita A; Jian G; Uchida N; Himoto T; Izuishi K; Iwama H; Yoshiji H; Watanabe S; Kurokohchi K; Kuriyama S
Int J Oncol; 2007 Jan; 30(1):105-11. PubMed ID: 17143518
[TBL] [Abstract][Full Text] [Related]
10. [Monoclonal antibody against human primary hepatocellular carcinoma and immunocytochemical localization of the corresponding antigen].
Ren F
Zhonghua Zhong Liu Za Zhi; 1991 May; 13(3):196-9. PubMed ID: 1664795
[TBL] [Abstract][Full Text] [Related]
11. Granulin-epithelin precursor overexpression promotes growth and invasion of hepatocellular carcinoma.
Cheung ST; Wong SY; Leung KL; Chen X; So S; Ng IO; Fan ST
Clin Cancer Res; 2004 Nov; 10(22):7629-36. PubMed ID: 15569995
[TBL] [Abstract][Full Text] [Related]
12. Localization of thrombospondin in hepatocellular carcinoma.
Hayashi K; Kurohiji T; Shirouzu K
Hepatology; 1997 Mar; 25(3):569-74. PubMed ID: 9049200
[TBL] [Abstract][Full Text] [Related]
13. New human hepatocellular carcinoma (HCC) cell line with highly metastatic potential (MHCC97) and its expressions of the factors associated with metastasis.
Tian J; Tang ZY; Ye SL; Liu YK; Lin ZY; Chen J; Xue Q
Br J Cancer; 1999 Nov; 81(5):814-21. PubMed ID: 10555751
[TBL] [Abstract][Full Text] [Related]
14. HAb18G/CD147 functions in invasion and metastasis of hepatocellular carcinoma.
Xu J; Xu HY; Zhang Q; Song F; Jiang JL; Yang XM; Mi L; Wen N; Tian R; Wang L; Yao H; Feng Q; Zhang Y; Xing JL; Zhu P; Chen ZN
Mol Cancer Res; 2007 Jun; 5(6):605-14. PubMed ID: 17579119
[TBL] [Abstract][Full Text] [Related]
15. [Internalization of monoclonal antibodies against human hepatoma in the target cells].
Ji Y
Zhonghua Yi Xue Za Zhi; 1991 Jul; 71(7):369-72, 26. PubMed ID: 1659477
[TBL] [Abstract][Full Text] [Related]
16. The role of the tumor necrosis factor (TNF)--Fas L and HCV in the development of hepatocellular carcinoma.
Nada O; Abdel-Hamid M; Ismail A; El Shabrawy L; Sidhom KF; El Badawy NM; Ghazal FA; El Daly M; El Kafrawy S; Esmat G; Loffredo CA
J Clin Virol; 2005 Oct; 34(2):140-6. PubMed ID: 16157266
[TBL] [Abstract][Full Text] [Related]
17. [Immunohistochemical study of transferrin receptor expression in hepatocellular carcinoma].
Lin J
Zhonghua Yi Xue Za Zhi; 1992 Feb; 72(2):86-7, 128. PubMed ID: 1327439
[TBL] [Abstract][Full Text] [Related]
18. Comparison study of the expressions of myristoylated alanine-rich C kinase substrate in hepatocellular carcinoma, liver cirrhosis, chronic hepatitis, and normal liver.
Masaki T; Tokuda M; Yoshida S; Nakai S; Morishita A; Uchida N; Funaki T; Kita Y; Funakoshi F; Nonomura T; Himoto T; Deguchi A; Kimura Y; Izuishi K; Wakabayashi H; Usuki H; Yoshiji H; Watanabe S; Kurokohchi K; Kuriyama S
Int J Oncol; 2005 Mar; 26(3):661-71. PubMed ID: 15703821
[TBL] [Abstract][Full Text] [Related]
19. [Relationship between death receptor 5 and apoptosis in hepatocellular carcinoma].
Zhu RX; Lin JS; Song YH; Li PY; Tao LW
Zhonghua Zhong Liu Za Zhi; 2006 Apr; 28(4):261-4. PubMed ID: 16875623
[TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical localization of endothelin-1/big endothelin-1 in normal liver, liver cirrhosis and hepatocellular carcinoma.
Suzuki T; Hoshi N; Watanabe K; Kasukawa R; Suzuki T
Fukushima J Med Sci; 1998 Dec; 44(2):93-105. PubMed ID: 10091381
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
